“…19 Primary antibodies used were anti-alpha-1-antitrypsin (AAT) (prediluted, Dako, Carpinteria, California, U.S.A.) polyclonal and anti-neuron specific enolase (NSE) (prediluted, Biomeda, Foster City, California, U.S.A.) monoclonal antibody. Furthermore, antichromogranin A (1:100), antiinsulin (1:300), antisomatostatin (1:300), antiglucagon (1:600) and antipancreatic polypeptides (1:600) polyclonal antibodies (Dako), antigastrin polyclonal antibody produced in our laboratory, 14 and antiserotonin monoclonal antibody (Dako, 1:10) were used for the tissue sections of all cases of SCT to eliminate the possibility of islet cell tumor. As a negative control, nonimmunized rabbit or mouse immunoglobulins were used instead of the primary antibodies, and negative results were obtained.…”